FDA Investigator: Yun Wu
- Yun Wu first started conducting FDA inspections in 2020, with the last inspection in 2023. Over that time, Yun Wu has conducted 10 inspections at 10 companies across 10 sites.
Get Yun Wu's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Patheon Biologics Australia Pty Ltd, Woolloongabba | 2023
Out-of-stock
Yun Wu
Human Drugs Form 483
FDA 483 Akeso Biopharma, Co., Ltd., Zhongshan | 2023
Out-of-stock
Yun Wu
Human Drugs Form 483
FDA 483 Tanvex BioPharma USA, Inc, San Diego | 2022
Out-of-stock
Yun Wu
Human Drug Form 483
FDA 483 Samsung Biologics Co., Ltd., Incheon | 2021
Out-of-stock
Yun Wu
Human Drug Form 483
FDA 483 FujiFilm Diosynth Biotechnologies U.S.A., Inc., Research Triangle Park | 2021
Out-of-stock
Yun Wu
Human Drug Form 483
FDA 483 Patheon Manufacturing Services LLC, Greenville | 2020
Out-of-stock
Yun Wu
Human Drug Form 483
FDA 483 Novartis Singapore Pharmaceutical Manufacturing Pte., Singapore | 2020
Out-of-stock
Yun Wu
Human Drug Form 483
Co-Investigators (12)
- Michael Shanks, FDA Investigator
- Zhong Li, FDA Investigator
- Cassandra L. Abellard, FDA Investigator
- Christopher R. Czajka, FDA Investigator
- Junho Pak, FDA Investigator
- Maria G. Gutierrez-Hoffman, FDA Investigator
- Arulvathani P. Arudchandran, FDA Investigator
- Seneca D. Toms, FDA Investigator
- Jacek Cieslak, FDA Investigator
- Zhihao Pete Qiu, FDA Investigator
- Viviana Matta, FDA Investigator
- Thuy T. Nguyen, FDA Investigator